US pharma giant Pfizer has ended all development and commercialization activities relating to fidanacogene elaparvovec, a ...
Here's why a gene therapy product originally developed at CHOP spinout Spark Therapeutics was shelved by Pfizer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback